HEART FAILURE : AN EPIDEMICS OF THE 21ST CENTURY
	Institut Pasteur , Paris, France June 26-27, 2000
	Chronic Heart Failure (CHF) is a major cardiovascular disease with progressive prevalence and incidence. In spite of multiple pharmacotherapies, the disease has high morbidity, mortality and financial burden to patients and the society at large. The CHF EUROCONFERENCE is aimed to provide a comprehensive analysis and discussion on the genetics, molecular biology, metabolic, pharmacology and clinical issues to be faced in the 21st century management of CHF. In particular, the epidemiologics and pharmacogenetic aspects will be reviewed, followed by the analysis of the role of ion channels, the novel discoveries in the field of immune mechanisms and growth factors, signal transduction as a potential drug target, the general problems raised by myocyte survival, particularly in the field of apoptosis, remodeling, cytoskeletal pathways. The academic and industrial points of view will be compared and thoroughly analyzed.
	Organized by:	Institut Pasteur
	Invited Speakers:	Scientific Committee: K. CHIEN G. FEUERSTEIN M. KOMAJDA K. SCHWARTZ
	Deadline for Abstracts:	April, 2000
	Registration:	Institut Pasteur EuroConferences 28 rue du Docteur Roux 75724 Paris Cedex 15, France. fax: 33 (0)1 40 61 34 05 http://www.pasteur.fr/applications/euroconf/
	Email for Requests and Registration:	euroconf@pasteur.fr
	Posted by: Drye Ludovic   Host: 157.99.64.24 date: December 13, 1999 16:16:33 Generated by meetings and positions 2.0 by Kai Garlipp Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany. 4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright.